These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32566910)

  • 1. Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.
    Landersdorfer CB; Kinzig M; Höhl R; Kempf P; Nation RL; Sörgel F
    ACS Pharmacol Transl Sci; 2020 Jun; 3(3):444-454. PubMed ID: 32566910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach.
    Landersdorfer CB; Lee WL; Nation RL; Kong DCM; Buising K; Peel TN; Choong PFM
    Mol Pharm; 2023 Mar; 20(3):1509-1518. PubMed ID: 36512679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin.
    Chen Q; Tung EC; Ciccotto SL; Strauss JR; Ortiga R; Ramsay KA; Tang W
    Xenobiotica; 2008 Jan; 38(1):76-86. PubMed ID: 17963190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentration of ciprofloxacin in bone tissue].
    Meissner A; Borner K
    Aktuelle Traumatol; 1993 Apr; 23(2):80-4. PubMed ID: 8098576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery.
    Gergs U; Clauss T; Ihlefeld D; Weiss M; Pönicke K; Hofmann GO; Neumann J
    J Pharm Pharmacol; 2014 Nov; 66(11):1552-8. PubMed ID: 24941934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin concentrations in bone and muscle after oral dosing.
    Fong IW; Ledbetter WH; Vandenbroucke AC; Simbul M; Rahm V
    Antimicrob Agents Chemother; 1986 Mar; 29(3):405-8. PubMed ID: 2940971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection.
    Sadiq MW; Nielsen EI; Khachman D; Conil JM; Georges B; Houin G; Laffont CM; Karlsson MO; Friberg LE
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):69-79. PubMed ID: 27578330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats.
    Zimmermann ES; de Miranda Silva C; Neris C; Torres BGDS; Schmidt S; Dalla Costa T
    Eur J Pharm Sci; 2019 Jan; 127():319-329. PubMed ID: 30423435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion of cefepime into cancellous and cortical bone tissue.
    Breilh D; Boselli E; Bel JC; Chassard D; Saux MC; Allaouchiche B
    J Chemother; 2003 Apr; 15(2):134-8. PubMed ID: 12797389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone and Joint Tissue Penetration of the
    Menetrey A; Janin A; Pullman J; Overcash JS; Haouala A; Leylavergne F; Turbe L; Wittke F; Nicolas-Métral V
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose pharmacokinetics of vancomycin in porcine cancellous and cortical bone determined by microdialysis.
    Bue M; Birke-Sørensen H; Thillemann TM; Hardlei TF; Søballe K; Tøttrup M
    Int J Antimicrob Agents; 2015 Oct; 46(4):434-8. PubMed ID: 26260192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetic Modeling as a Tool To Characterize the Decrease in Ciprofloxacin Free Interstitial Levels Caused by Pseudomonas aeruginosa Biofilm Lung Infection in Wistar Rats.
    Torres BGS; Helfer VE; Bernardes PM; Macedo AJ; Nielsen EI; Friberg LE; Dalla Costa T
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion of levofloxacin into bone and synovial tissues.
    Rimmelé T; Boselli E; Breilh D; Djabarouti S; Bel JC; Guyot R; Saux MC; Allaouchiche B
    J Antimicrob Chemother; 2004 Mar; 53(3):533-5. PubMed ID: 14963066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections.
    Zahr N; Urien S; Aubry A; Chauvin C; Comets E; Llopis B; Tissot N; Noe G; Fourniols E; Jaureguiberry S; Bleibtreu A; Funck-Brentano C;
    J Antimicrob Chemother; 2021 Oct; 76(11):2906-2913. PubMed ID: 34363656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin pharmacokinetics in burn patients.
    Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
    Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion of isepamicin into cancellous and cortical bone tissue.
    Boselli E; Breilh D; Bel JC; Debon R; Saux MC; Chassard D; Allaouchiche B
    J Chemother; 2002 Aug; 14(4):361-5. PubMed ID: 12420853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches.
    Conil JM; Georges B; de Lussy A; Khachman D; Seguin T; Ruiz S; Cougot P; Fourcade O; Houin G; Saivin S
    Int J Antimicrob Agents; 2008 Dec; 32(6):505-10. PubMed ID: 18768301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.